摘要
戊型病毒型肝炎(viral hepatitis E,HEV,以下简称戊肝或戊型肝炎),是由戊型肝炎型病毒引起的经消化道传染性疾病,主要在发展中国家流行。然而,近年来在发达国家也日益严重,成为新进的具有严重威胁的全球公共卫生问题,能够使孕妇和潜在慢性肝病患者的死亡率分别高达25%和75%,且至今无有效治疗措施。国内外正积极探索戊型肝炎的治疗药物,调查结果显示中西结合的治疗方式较单独使用中、西药有着极大优势,为此做出如下综述。
Viral hepatitis E(HEV) is a kind of trans-alimentary tract infectious disease caused by hepatitis E virus. It is mainly prevalent in developing countries. But in recent years, with the expansion of the transmission range, HEV has also become increasingly serious in developed countries. It is considered to be a new global public health problem with serious threats, which can particularly cause significant mortality in pregnant women and patients with cirrhosis, and there is no effective treatment so far. The therapeutic drugs for hepatitis E are actively explored at home and abroad. The survey results show that the combination of Chinese and Western medicine has great advantages over the use of Chinese and Western medicine alone. The following is a review on it.
作者
马小龙
吴欢
尹冬梅
郑晓玉
杨雪莲
姚佳圆
Ma Xiaolong;Wu Huan;Yin Dongmei;Zheng Xiaoyu;Yang Xulian;Yao Jiayuan(School of clinical laboratory,Wannan Medical College,Wuhu,Anhui,241002,China)
出处
《齐齐哈尔医学院学报》
2022年第12期1175-1179,共5页
Journal of Qiqihar Medical University
基金
皖南医学院2020年度校级重点项目科研基金(WK2020Z19)
国家级大学生创新创业训练项目(202010368020)。
关键词
戊型肝炎
药物治疗
联合用药
Hepatitis E
Drug treatment
Drug combination
